Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter ...
The touchstone of the ABT Sportsline Audi SQ5 kit is a unique software upgrade that uncorks 440 horsepower and 443 pound-feet ...
Despite the modern features and amenities, family values and an old-fashioned approach to doing business are the backbone of ...
The new SQ5 just got a series of upgrades from ABT, adding power, stance, and the attitude Ingolstadt forgot to include.
ABT Sportsline has been turning various Volkswagen Group vehicles into better and sometimes faster rides for many years, and you can probably remember the Legacy Edition (LE) versions of the RS 6 ...
Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 ...
ABT Sportsline has prepared some exterior add-ons, a set of new wheels, a few interior extras, and a power boost for the 2026 ...
Even the best of the best can still enjoy an upgrade sometimes. Compared with the standard model, the RS Q8 Signature Edition can really fly. It ups the horsepower from 600 hp to 800 hp, increases ...
The €110,000 (US$120,000) Audi RS6 Avant has been the highest performance variant in the Audi A6 range since 2002, and is now only available in estate car guise: an eccentric combination of 600 hp ...
ABT Sportsline has a long history of performance, and this new ABT RS7-R fits in perfectly with its brethren. It’s based on the 2020 Audi RS 7. If you happen to own one of those rockets (0-62 mph in 3 ...
Senior Market Sales(R) (SMS), one of the industry's premier field marketing organizations (FMOs), has acquired the rapidly growing Abt Insurance Agency, further expanding the FMO's Medicare insurance ...
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Figure 3: High BCL-2 expression predicts sensitivity to ABT-199 in NHL cell lines. Figure 4: ABT-199 inhibits xenograft growth as a single agent or in combination with rituximab and bendamustine.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results